Haojun Xiong

905 total citations
26 papers, 675 citations indexed

About

Haojun Xiong is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Haojun Xiong has authored 26 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Haojun Xiong's work include Autophagy in Disease and Therapy (9 papers), Ubiquitin and proteasome pathways (5 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Haojun Xiong is often cited by papers focused on Autophagy in Disease and Therapy (9 papers), Ubiquitin and proteasome pathways (5 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Haojun Xiong collaborates with scholars based in China, United States and India. Haojun Xiong's co-authors include Fengtian He, Jianzhong He, Zhenhong Ni, Xilin Lyu, Gang Huang, Bin Li, Ning Zhang, Weijuan Gong, Lei Zheng and Xiao Li and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Haojun Xiong

25 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haojun Xiong China 11 476 371 202 76 47 26 675
Yang Cheng China 14 331 0.7× 206 0.6× 144 0.7× 63 0.8× 55 1.2× 36 606
Kwong‐Fai Wong Hong Kong 14 657 1.4× 450 1.2× 141 0.7× 67 0.9× 46 1.0× 18 973
Mabel T. Padilla United States 13 423 0.9× 181 0.5× 146 0.7× 99 1.3× 22 0.5× 15 597
Bhupender Kumar India 15 315 0.7× 173 0.5× 100 0.5× 57 0.8× 26 0.6× 28 490
Jiexia Ding China 10 224 0.5× 169 0.5× 257 1.3× 32 0.4× 50 1.1× 16 539
Lizhi Lv China 13 235 0.5× 150 0.4× 81 0.4× 100 1.3× 48 1.0× 42 487
Jiangning Gu China 13 269 0.6× 158 0.4× 126 0.6× 158 2.1× 62 1.3× 29 515
Juan L. García‐Rodríguez Spain 10 298 0.6× 103 0.3× 171 0.8× 80 1.1× 54 1.1× 20 511
Laura Ruíz-Cañas Spain 10 237 0.5× 106 0.3× 147 0.7× 103 1.4× 35 0.7× 22 496
Wen-Dan Chen China 10 307 0.6× 92 0.2× 218 1.1× 65 0.9× 15 0.3× 10 518

Countries citing papers authored by Haojun Xiong

Since Specialization
Citations

This map shows the geographic impact of Haojun Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojun Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojun Xiong more than expected).

Fields of papers citing papers by Haojun Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haojun Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojun Xiong. The network helps show where Haojun Xiong may publish in the future.

Co-authorship network of co-authors of Haojun Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Haojun Xiong. A scholar is included among the top collaborators of Haojun Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haojun Xiong. Haojun Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Ming, Dong Liu, Lingxi Chen, et al.. (2025). Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy. Cell Death and Differentiation. 32(9). 1630–1647. 1 indexed citations
2.
Yu, Hongqiang, Yuanhang Ma, Ying Wu, et al.. (2025). F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression. Nature Communications. 16(1). 4060–4060. 2 indexed citations
3.
Fang, Lei, Xingxing Su, Jie Zhang, et al.. (2025). Macrophage miR-4524a-5p/TBP promotes β-TrCP -TIM3 complex activation and TGFβ release and aggravates NAFLD-associated fibrosis. Cell Death and Disease. 16(1). 315–315. 3 indexed citations
4.
Yao, Shuyang, Lin Li, Haojun Xiong, et al.. (2025). The involvement of arbuscular mycorrhizal fungi in modulating polyamine metabolism and low-temperature tolerance enhancement in white clover. Frontiers in Plant Science. 16. 1571852–1571852.
6.
He, Ming, Di Wu, Ping Zheng, et al.. (2024). Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology Communications. 8(4). 7 indexed citations
7.
He, Haiyan, Ming He, Haojun Xiong, et al.. (2024). Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway. Experimental Cell Research. 439(1). 114094–114094. 1 indexed citations
8.
Li, Xiang, et al.. (2024). Androgen receptor cofactors: A potential role in understanding prostate cancer. Biomedicine & Pharmacotherapy. 173. 116338–116338. 10 indexed citations
9.
Li, Dongqing, et al.. (2024). Efficacy of fractional radiofrequency in the treatment of erythematous capillary rosacea: A split‐face study. Journal of Cosmetic Dermatology. 23(9). 2895–2904. 2 indexed citations
10.
Li, Feng, Hongye He, Yi Gong, et al.. (2023). Silencing of FAM111B inhibited proliferation, migration and invasion of hepatoma cells through activating p53 pathway. Digestive and Liver Disease. 55(12). 1679–1689. 6 indexed citations
11.
Chen, Yan, Sha Yi, Qing Wang, et al.. (2023). Lutein attenuates Propionibacterium acnes-induced inflammation by inhibiting pyroptosis of human keratinocyte cells via TLR4/NLRP3/Caspase-1 pathway. International Immunopharmacology. 117. 109937–109937. 5 indexed citations
12.
Xiong, Haojun, Xufang Dai, Xiaojing Yan, et al.. (2022). Deacetylation of ATG4B promotes autophagy initiation under starvation. Science Advances. 8(31). eabo0412–eabo0412. 30 indexed citations
13.
Xiong, Haojun, et al.. (2022). Involvement of acetylation of ATG4B in controlling autophagy induction. Autophagy. 19(3). 1039–1041. 9 indexed citations
14.
Wu, Di, Hongqiang Yu, Haojun Xiong, et al.. (2021). Elevated Sodium Pump α3 Subunit Expression Promotes Colorectal Liver Metastasis via the p53-PTEN/IGFBP3-AKT-mTOR Axis. Frontiers in Oncology. 11. 743824–743824. 4 indexed citations
15.
Li, Xinzhe, Bo Li, Zhenhong Ni, et al.. (2017). Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells. Molecular Cancer Therapeutics. 16(9). 1806–1818. 18 indexed citations
16.
Xiong, Haojun, Bo Li, Jintao He, et al.. (2017). lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein. Biochemical and Biophysical Research Communications. 490(3). 693–699. 55 indexed citations
17.
Xiong, Haojun, Yan Zhang, Shan Chen, et al.. (2017). Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells. Oncotarget. 8(38). 64083–64094. 17 indexed citations
18.
Zhang, Nan, Yaran Wu, Xilin Lyu, et al.. (2017). HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells. Cancer Letters. 409. 81–90. 38 indexed citations
19.
Xiong, Haojun, Zhenhong Ni, Jianzhong He, et al.. (2017). LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 36(25). 3528–3540. 311 indexed citations
20.
Zhao, Kai, Jialin He, Yan Zhang, et al.. (2016). Activation of FXR protects against renal fibrosis via suppressing Smad3 expression. Scientific Reports. 6(1). 37234–37234. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026